References
- Rabodonirina M., Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infec-tion after single-lung transplantation. Clin Infect Dis 1994; 19: 138–42.
- Tekavec J, Mlinaric-Missoni E, Babic-Vazic V. Pulmonary tuberculosis associated with invasive pseudallescheriasis. Chest 1997; 111: 508–11.
- Wood GM, McCormack JG, Muir DB, et al. Clinical fea-tures of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027–33.
- Husain S, Alexander B, Munoz P, et al. Opportunistic mycelial fungi in organ transplant recipients: emerging impor-tance of non-Aspergillus mycelial infections. Clin Infect Dis 2003; 37: 221–9.
- Munoz P, Mann M, Tornero P, Martin P, Rodriguez-Creixem RM, Souza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000; 31: 499–501.
- Kershaw P, Freeman R, Templeton D, et al. Psueudoallescheria boydii infection of the central nervous system. Arch Neurol 1990; 47: 468–72.
- Idigoras P, Perez-Trallero E, Pineiro L, et al. Disseminated infection and colonization by Scedosporiumprolificans: a review of 18 cases 1990-1999. Clin Infect Dis 2001; 32: e158–65.
- Steimbach WJ, Schell VA, Miller JL, Perfect JR. Scedosporium prolificans osteomyelitis in an immunocompe-tent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol 2003; 41: 3981–5.
- Bouza E, Munoz P, Vega L, Rodriguez-Creixem M, Berenguer J, Escudero A. Clinical resolutionof Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating fac-tor. Clin Infect Dis 1996; 23: 192–3.
- Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in vitro activity of voriconazole and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149–51.
- Meletiadis J, Meis JFGM, Mouton JW, Rodriguez-Tudela JL, Donnelly JP, Verweij PE. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. J Clin Microbiol 2002; 46: 62–8.
- Carrillo-Munoz AJ, Quindos G, Tur C et al. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B, and fluconazole. Chemotherapy 2000; 46: 235–44.
- Cano AJ, Guarro J. In vitro activities of four novel tria-zoles against Scedosporium spp. Antimicrob Agents Chemother 2001; 45: 2151–3.
- Tascini C, Bongiorni MG, Gemignani G et al. Non-inva-sive management of infections related to pacemakers and indwelling cardiac defibrillator [1462]. In: Proceedings of the 41” Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago) 2001.